Table 2.
Group | OPLS-DA | p-valueb | |||
---|---|---|---|---|---|
Componentsa | Q2 | R2 | Q2/R2 | ||
GD-LCKD | |||||
Week 0–0 | 5 | 0.470 | 0.943 | 0.50 | 0.055 |
Week 2–2 | 1 | 0.555 | 0.964 | 0.58 | 0.024 |
Week 4–4 | 3 | 0.608 | 0.938 | 0.65 | 0.057 |
GD-GD | |||||
Week 0–2 | 6 | 0.554 | 0.998 | 0.60 | 0.129 |
Week 0–4 | 5 | 0.470 | 1.000 | 0.47 | 0.181 |
Week 2–4 | 3 | 0.569 | 0.999 | 0.57 | 0.174 |
LCKD-LCKD | |||||
Week 0–2 | 6 | 0.780 | 1.000 | 0.78 | 0.120 |
Week 0–4 | — | — | — | — | — |
Week 2–4 | 7 | 0.649 | 1.000 | 0.65 | 0.525 |
aThe number of components based on Q2 indicates the best classifier of OPLS-DA using a 7-fold cross-validation method.
bp-value was determined by CV-ANOVA of OPLS-DA in SIMCA 14.1. p < 0.05 was considered significant.
CV-ANOVA, cross-validated analysis of variance; OPLS-DA, orthogonal partial least squares discriminant analysis; Q2, predictive capability; R2, goodness of fit. OPLS-DA not performed was shown as “—”.